Neoral therapy in liver transplantationLEVY, G. A.Transplantation proceedings. 1996, Vol 28, Num 4, pp 2225-2228, issn 0041-1345Conference Paper

Relationship of pharmacokinetics to clinical outcomes : Guidelines for the use of cyclosporine formulationsLEVY, G. A.Transplantation proceedings. 1999, Vol 31, Num 3, pp 1654-1658, issn 0041-1345Conference Paper

Neoral C₂ in liver transplant recipientsLEVY, G. A.Transplantation proceedings. 2001, Vol 33, Num 7-8, pp 3089-3091, issn 0041-1345Article

The prothrombinase activity of FGL2 contributes to the pathogenesis of experimental arthritisMELNYK, M. C; SHALEV, I; LEVY, G. A et al.Scandinavian journal of rheumatology. 2011, Vol 40, Num 4, pp 269-278, issn 0300-9742, 10 p.Article

Hepatitis C-related cirrhosis : A predictor of diabetes after liver transplantationBIGAM, D. L; PENNINGTON, J. J; CATTRAL, M. S et al.Hepatology (Baltimore, Md.). 2000, Vol 32, Num 1, pp 87-90, issn 0270-9139Article

Pretreatment of donor stimulator cells by 16,16 dimethyl prostaglandin E₂ influences the recipient immune responseCHUNG, S. W; GOULD, B; RUIMIN ZHANG et al.Surgery. 1998, Vol 123, Num 2, pp 171-180, issn 0039-6060Article

Outcome of kidney transplantation alone versus synchronous pancreas-kidney transplantion in type 1 diabeticsCATTRAL, M. S; HEMMING, A. W; GREIG, P. D et al.Transplantation proceedings. 1998, Vol 30, Num 5, pp 1938-1939, issn 0041-1345Conference Paper

Excess zinc associated with severe progressive cholestasis in Cree and Ojibwa-Cree childrenPHILLIPS, M. J; ACKERLEY, C. A; SUPERINA, R. A et al.Lancet (British edition). 1996, Vol 347, Num 9005, pp 866-868, issn 0140-6736Article

Hepatotoxicity of immunomodulating agentsFINGEROTE, R. J; LEVY, G. A.Handbook of experimental pharmacology. 1996, Vol 121, pp 581-609, issn 0171-2004Article

Isolation and identification of twocyclosporine aldehydic metabolites from the bile of a liver transplant recipient during an acute nephrotoxic episodeDUNCAN, S; LIU, W. T; LEVY, G. A et al.Transplantation proceedings. 1994, Vol 26, Num 5, pp 2899-2901, issn 0041-1345Conference Paper

Monoclonal antibody analysis of a unique macrophage procoagulant activity induced by murine hepatitis virus strain 3 infectionLAI SUM FUNG; NEIL, G; LEIBOWITZ, J et al.The Journal of biological chemistry (Print). 1991, Vol 266, Num 3, pp 1789-1795, issn 0021-9258, 7 p.Article

Disparate mechanisms of induction of procoagulant activity by live and inactivated bacteria and virusesSINCLAIR, S. B; ROTSTEIN, O. D; LEVY, G. A et al.Infection and immunity. 1990, Vol 58, Num 6, pp 1821-1827, issn 0019-9567, 7 p.Article

Treatment of primary liver graft nonfunction with prostaglandin E₁GREIG, P. D; WOOLF, G. M; LEVY, G. A et al.Transplantation. 1989, Vol 48, Num 3, pp 447-453, issn 0041-1337, 7 p.Article

Expression of macrophage procoagulant activity in murine systemic lupus erythematosusCOLE, E. H; SWEET, J; LEVY, G. A et al.The Journal of clinical investigation. 1986, Vol 78, Num 4, pp 887-893, issn 0021-9738Article

The α-Gal analog GAS914 ameliorates delayed rejection of hDAF transgenic pig-to-baboon renal xenograftsGHANEKAR, A; LUO, Y; WALL, W et al.Transplantation proceedings. 2001, Vol 33, Num 7-8, pp 3853-3854, issn 0041-1345Article

A pharmacoeconomic analysis of Neoral without intravenous cyclosporine in liver transplantation in CanadaHEMMING, A. W; CATTRAL, M. S; GREIG, P. D et al.Clinical transplantation. 1998, Vol 12, Num 5, pp 425-429, issn 0902-0063Article

Kupffer cell erythrophagocytosis and graft-versus-host hemolysis in liver transplantationCLAVIEN, P.-A; CAMARGO, C. A; CAMERON, R et al.Gastroenterology (New York, NY. 1943). 1996, Vol 110, Num 6, pp 1891-1896, issn 0016-5085Article

Characterization of the procoagulant-inducing factor derived from the plasma of BXSB miceCOLE, E. H; NEIL, G; MYERS-MASON, N et al.Journal of autoimmunity (Print). 1995, Vol 8, Num 1, pp 47-59, issn 0896-8411Article

Measurement of AM19 and other cyclosporine metabolites in the blood of liver transplant patients with stable liver functionLIU, W. T; LEVY, G. A; WONG, P. Y et al.Therapeutic drug monitoring. 1995, Vol 17, Num 5, pp 479-486, issn 0163-4356Article

Prediction of the outcome of transplantation in man by platelet adherence in donor liver allograftsCYWES, R; BRENDAN, J; MULLEN, M et al.Transplantation. 1993, Vol 56, Num 2, pp 316-323, issn 0041-1337Article

Effect of eicosanoids on induction of procoagulant activity by murine hepatitis virus strain 3 in vitroCHUNG, S. W; SINCLAIR, S. B; FUNG, L. S et al.Prostaglandins. 1991, Vol 42, Num 6, pp 501-513, issn 0090-6980Article

The comparative effects of cyclosporin A and 16,16 dimethyl prostaglandin E₂ on the allogeneic induction of monocyte/macrophage procoagulant activity and the cytokines macrophages procoagulant inducing factor and interleukin-2CHUNG, S. W; KIM, P. C. W; KOH, I. H. J et al.Immunology (Oxford). 1991, Vol 74, Num 4, pp 670-676, issn 0019-2805Article

Dissociation between the immunosuppressive activity of cyclosporine derivatives and their effects on intracellular calcium signaling in mesangial cellsGOLDBERG, H. J; WONG, P. Y; COLE, E. H et al.Transplantation. 1989, Vol 47, Num 4, pp 731-733, issn 0041-1337Article

Susceptibility/resistance to mouse hepatitis virus strain 3 and macrophage procoagulant activity are genetically linked and controlled by two non-H-2-linked genesDINDZANS, V. J; SKAMENE, E; LEVY, G. A et al.The Journal of immunology (1950). 1986, Vol 137, Num 7, pp 2355-2360, issn 0022-1767Article

Monocyte procoagulant activity in glomerulonephritis associated with systemic lupus erythematosusCOLE, E. H; SCHULMAN, J; UROWITZ, M et al.The Journal of clinical investigation. 1985, Vol 75, Num 3, pp 861-868, issn 0021-9738Article